Pharmaceutical News

RSS

Common drug for allergies and asthma could prevent fibrosis, reduce need for liver transplants

A drug commonly used for the prevention of allergies and asthma someday could find new use in preventing liver disease and reducing the need for transplants, according to new research published in the October 2016 edition of the scientific journal Hepatology.

12 Oct 2016

Study suggests possibility for small molecule drug/antibody combinatorial therapy to treat neuroblastoma

A study by a multidisciplinary team of researchers from The Saban Research Institute of Children's Hospital Los Angeles sheds further light on the role of the cytokine TGFβ1 in the growth of neuroblastoma, and suggests the possibility for a small molecule drug/antibody combinatorial therapy to treat this cancer.

12 Oct 2016

Community outreach workers may help increase HBV vaccination rates to cut risk of liver cancer

Liver cancer is more common among Asian Americans in part because they are at high risk of HBV infection.

12 Oct 2016

$Heavy cannabis users have large reduction in bone density, increased risk of bone fractures$

Heavy cannabis users have large reduction in bone density, increased risk of bone fractures

People who regularly smoke large amounts of cannabis have reduced bone density and are more prone to fractures, research has found.

12 Oct 2016

Treating volatile exhaust streams in the pharmaceutical industry: an interview with Jeff Kudronowicz

Capturing and destroying harmful emissions from pharmaceutical processes can be challenging. It’s not because the pollutants, referred to as volatile organic compounds (VOCs) or hazardous air pollutants (HAPs) are difficult to destroy using catalytic or thermal technologies.

From Anguil Environmental Systems 12 Oct 2016

Calcium supplements may raise risk of plaque buildup in arteries and heart damage

After analyzing 10 years of medical tests on more than 2,700 people in a federally funded heart disease study, researchers at Johns Hopkins Medicine and elsewhere conclude that taking calcium in the form of supplements may raise the risk of plaque buildup in arteries and heart damage, although a diet high in calcium-rich foods appears be protective.

12 Oct 2016

Study shows simple and convenient oral spray supplementation can help correct vitamin D deficiency

Optimal levels of vitamin D are just a spray away, according to a study by health pioneers BetterYou in conjunction with the NHS.

From BetterYou Ltd 12 Oct 2016

DHA supplementation enhances cognitive function in older adults with MCI

Results from a recent study published in the Journal of Alzheimer's Disease support the cognitive benefits of DHA, which have been consistently demonstrated with doses of 900 mg/day or greater.

12 Oct 2016

Botanical supplements may reduce effectiveness of common anti-tuberculosis drug, study finds

Botanical supplements are used by people around the world to treat a wide range of physical and mental ailments. Some of these botanical supplements have high levels of antioxidants, which may have some positive health effects for certain conditions.

12 Oct 2016

Study to examine efficacy of orally administered medication in treating stuttering

Stuttering, an interruption in the flow of speech, affects about three million Americans. It begins most often in childhood, affecting four men for every woman. A precise cause of this complex communicative disorder is not known.

8 Oct 2016

Combination treatment for myocardial infarction shows no added benefit compared to ASA monotherapy

The drug ticagrelor has been approved since February 2016 for adults who had a myocardial infarction a year or more ago and are at a high risk of a new myocardial infarction or stroke.

8 Oct 2016

Researchers describe novel host-oriented therapeutic approach for preventing lethal immune responses

Staphylococcal and streptococcal infections affect millions of individuals each year. They are a leading cause of sepsis and account for many cases of pneumonia and post-surgical infections.

8 Oct 2016

Study of pan-FGFR inhibitor uses mRNA in tumours to identify responders

The first-in-human dose escalation study of the pan-FGFR (fibroblast growth factor receptor) inhibitor BAY 1163877 in patients with treatment-refractory locally advanced or metastatic solid tumours were reported today at the ESMO 2016 Congress in Copenhagen.

8 Oct 2016

Ethosomes may be effective carrier system for transdermal delivery

Ethosomes are ethanolic nanovesicles that possess abundant amount of ethanol in its core which provides fluidity to the lipid bilayers and thus by this effect, improves the delivery of molecules into the deep skin layers.

7 Oct 2016

Virginia Tech scientists solve structure of enzyme that deactivates important antibiotic

A popular antibiotic called rifampicin, used to treat tuberculosis, leprosy, and Legionnaire's disease, is becoming less effective as the bacteria that cause the diseases develop more resistance.

7 Oct 2016

Added benefit not proven for melanoma drug, IQWiG finds

Talimogene laherparepvec has been approved since December 2015 for adults with advanced melanoma.

7 Oct 2016

New study focuses on preserving microbe-fighting power of antibiotics

Of the 10 million prescriptions for antibiotics that emergency department physicians in the U.S. write each year, many are prescribed for known viral infections such as acute bronchitis and upper respiratory infections, which do not respond to antibiotics.

7 Oct 2016

No added benefit proven for pulmonary arterial hypertension drug, IQWiG finds

Selexipag is approved for long-term treatment of pulmonary arterial hypertension (PAH) in adults with moderate to severe symptoms.

7 Oct 2016

Survey reveals inequalities in access to new, life saving drugs for melanoma in Europe

Over 5000 patients with metastatic melanoma in Europe are denied access to new, life saving drugs every year, according to a survey presented at the ESMO 2016 Congress in Copenhagen.

7 Oct 2016

New study of Phase II Alzheimer's drug pipeline reveals more ways to combat disease

A new analysis of the Phase II Alzheimer's drug pipeline, conducted by ResearchersAgainstAlzheimer's, revealed 57 new Alzheimer's drugs. According to the analysis, nearly twice as many mechanisms of action are being tested in Phase II than in Phase III clinical trials.

7 Oct 2016

Pharmaceutical News

Common drug for allergies and asthma could prevent fibrosis, reduce need for liver transplants

Study suggests possibility for small molecule drug/antibody combinatorial therapy to treat neuroblastoma

Community outreach workers may help increase HBV vaccination rates to cut risk of liver cancer

Heavy cannabis users have large reduction in bone density, increased risk of bone fractures

Treating volatile exhaust streams in the pharmaceutical industry: an interview with Jeff Kudronowicz

Calcium supplements may raise risk of plaque buildup in arteries and heart damage

Study shows simple and convenient oral spray supplementation can help correct vitamin D deficiency

DHA supplementation enhances cognitive function in older adults with MCI

Botanical supplements may reduce effectiveness of common anti-tuberculosis drug, study finds

Study to examine efficacy of orally administered medication in treating stuttering

Combination treatment for myocardial infarction shows no added benefit compared to ASA monotherapy

Researchers describe novel host-oriented therapeutic approach for preventing lethal immune responses

Study of pan-FGFR inhibitor uses mRNA in tumours to identify responders

Ethosomes may be effective carrier system for transdermal delivery

Virginia Tech scientists solve structure of enzyme that deactivates important antibiotic

Added benefit not proven for melanoma drug, IQWiG finds

New study focuses on preserving microbe-fighting power of antibiotics

No added benefit proven for pulmonary arterial hypertension drug, IQWiG finds

Survey reveals inequalities in access to new, life saving drugs for melanoma in Europe

New study of Phase II Alzheimer's drug pipeline reveals more ways to combat disease

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Latest News